Brunschwig, C., Lawrence, N., Taylor, D., Abay, E., Njoroge, M., Basarab, G., . . . Chibale, K. (2018). UCT943, a next generation plasmodium falciparum PI4K inhibitor preclinical candidate for the treatment of malaria. American Society for Microbiology.
Chicago-viite (17. p.)Brunschwig, C., et al. UCT943, a Next Generation Plasmodium Falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria. American Society for Microbiology, 2018.
MLA-viite (9. p.)Brunschwig, C., et al. UCT943, a Next Generation Plasmodium Falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria. American Society for Microbiology, 2018.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.